Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia

ClinicalTrials.gov ID: NCT07841470

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07841470. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia: Randomized Comparison of Pulsed vs. Non-pulsed Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.

Study identification

NCT ID: NCT07841470
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Price Vision Group; Industry
Enrollment: 500 participants

Conditions and interventions

Conditions

Interventions

Riboflavin 0.1% ophthalmic solution and pulsed light Combination Product
Riboflavin 0.1% ophthalmic solution and non-pulsed light Combination Product

Combination Product

Eligibility (public fields only)

Age range: 10 Years to 90 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 1, 2025 (Actual)
Primary completion: Dec 31, 2030 (Estimated)
Completion: Jun 30, 2031 (Estimated)
Last update posted: Sep 25, 2026

2025 – 2031

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Price Vision Group	Indianapolis	Indiana	46260	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07841470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 25, 2026 · Synced Nov 15, 2026